chartexchange

Five Presentations, One Leading Innovation: Humacyte’s Acellular Tissue Engineered Vessel Takes Center Stage at VEITH 2026

GlobeNewswire Inc. | Nov 11, 2026 8:00 AM EST

– Presentations include interim Phase 3 results in women, integrated outcomes from three Phase 3 dialysis access trials and long-term human explant data.

Read original article